摘要
目的探究肺炎患者应用抗生素联合热毒宁的治疗效果以及安全性。方法抽取本院支气管肺炎患者60例作为研究对象,研究开展时间是2018年1月-2020年1月。将研究对象应用随机分组法分为对照、观察组,各30例。对照组采取抗生素治疗,观察组在对照组基础上采取热毒宁治疗,观察两组患者的治疗有效率、不良反应发生率以及临床症状恢复时间。结果对照组患者有效率是66.67%(20/30),观察组患者有效率是93.33%(28/30),数据的差异存在统计学显著性,P<0.05(χ^2=6.6670);不良反应发生率观察组患者为3.33%(1/30),对照组为20.00%(6/30),差异存在统计学意义,P<0.05(χ^2=4.0431);观察组的各项临床症状恢复时间显著低于对照组。结论肺炎患者应用抗生素联合热毒宁的治疗效果显著,值得应用。
Objective To explore the efficacy and safety of antibiotics combined with Reduning in patients with pneumonia.Methods Sixty patients with bronchial pneumonia in our hospital were selected as the research objects.The study was carried out from January 2018 to January 2020.The subjects were randomly divided into control group and observation group,with 30 cases in each group.The control group was treated with antibiotics,and the observation group was treated with Reduning on the basis of the control group.The treatment efficiency,the incidence of adverse reactions and the recovery time of clinical symptoms were observed in the two groups.Results The effective rate of patients in the control group was 66.67%(20/30),and the effective rate of patients in the observation group was 93.33%(28/30).The difference in data was statistically significant,P<0.05(χ^2=6.6670);The incidence of adverse reactions was 3.33%(1/30)in the observation group and 20.00%(6/30)in the control group.The difference was statistically significant,P<0.05(χ^2=4.0431).The recovery time of clinical symptoms in the observation group were significantly lower than that in the control group.Conclusion The treatment of pneumonia with antibiotics combined with Reduning is significant,and it is worth popularizing.
作者
梁春娜
李柏林
关彦钧
LIANG Chunna;LI Bailin;GUAN Yanjun(Department of Emergency,Kaiping Central Hospital,Kaiping Guangdong 529300,China)
出处
《中国卫生标准管理》
2020年第11期106-109,共4页
China Health Standard Management
关键词
抗生素
热毒宁
肺炎
临床效果
安全性
观察组
antibiotic
reduning
pneumonia
clinical effect
safety
observation group
